Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Drops 44 Points. More details...
CBT 200 Rises 26 Points. More details...
CBT 200 Falls Another 1.2%. More details...
Price Declines Bring Sector Into Buy Range. More details...
CBT 200 Makes A Gain. More details...
Any Blockbuster Announcements Likely?. More details...
CBT 200 Takes A Header. More details...
No Real Breakthrough But A Big Shift. More details...
CBT 200 Drops 3.3%. More details...
CBT 200 Drops Another 1%. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
